EMRELIS

NDC 0074-1044 · AbbVie Inc.

Generic nameTelisotuzumab Vedotin

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)TELISOTUZUMAB VEDOTIN

Strength20 mg/mL

Marketing categoryBLA

Packages

0074-1044-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1044-01) / 1 mL in 1 VIAL, SINGLE-DOSE

J9326 — Injection, telisotuzumab vedotin-tllv, 1 mg Medicare Part B payment limit (ASP + 6%): $146.06

FDA lists these products with the same active ingredient.

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.